Investigating the Benefits of CAS 35180-01-9 in Drug Formulation

Table of Contents

• 1. Introduction to CAS 35180-01-9


• 2. Chemical Properties of CAS 35180-01-9


• 3. The Role of CAS 35180-01-9 in Drug Formulation


• 4. Advantages of CAS 35180-01-9 in Pharmaceutical Development


• 5. Applications of CAS 35180-01-9 in Various Therapeutics


• 6. Safety and Regulatory Aspects of CAS 35180-01-9


• 7. Case Studies: Successful Implementations of CAS 35180-01-9


• 8. Future Trends in Drug Formulation Using CAS 35180-01-9


• 9. Conclusion


• 10. Frequently Asked Questions

1. Introduction to CAS 35180-01-9

CAS 35180-01-9, also known as a key pharmaceutical intermediate, has garnered significant attention in the field of drug formulation. As the pharmaceutical industry continually seeks to enhance drug efficacy and safety, understanding the benefits of this compound is crucial. The following sections will explore its chemical properties, role in drug formulation, and the potential advantages it offers to pharmaceutical development.

2. Chemical Properties of CAS 35180-01-9

CAS 35180-01-9 is characterized by its unique chemical structure, which contributes to its functionality in drug formulation. This compound possesses properties such as:
- **Molecular Formula:** C10H14N2O2
- **Molecular Weight:** 198.23 g/mol
- **Solubility:** Soluble in water and various organic solvents
- **Stability:** Exhibits stability under a variety of pH conditions
The molecular interactions of CAS 35180-01-9 make it an attractive choice for enhancing the delivery and effectiveness of therapeutic agents. Understanding these properties aids researchers in optimizing formulations for desired therapeutic outcomes.

3. The Role of CAS 35180-01-9 in Drug Formulation

In drug formulation, CAS 35180-01-9 serves multiple essential roles. Its primary functions include acting as a **stabilizer**, **solubilizer**, and **excipients** in various pharmaceutical products. By improving the solubility and bioavailability of active ingredients, CAS 35180-01-9 helps ensure that medications achieve their intended effects effectively and consistently.
Furthermore, the compound can facilitate the development of controlled-release formulations, allowing for prolonged therapeutic effects and improved patient compliance. These factors underscore the significance of CAS 35180-01-9 in the creation of effective medication.

4. Advantages of CAS 35180-01-9 in Pharmaceutical Development

The inclusion of CAS 35180-01-9 in drug formulation offers numerous advantages, including:
- **Enhanced Efficacy:** By improving solubility and bioavailability, CAS 35180-01-9 can significantly enhance the therapeutic efficacy of drugs.
- **Increased Stability:** The compound contributes to the overall stability of formulations, extending shelf life and maintaining drug integrity.
- **Versatile Application:** CAS 35180-01-9 can be utilized across various therapeutic classes, including analgesics, antibiotics, and anti-cancer medications.
- **Cost-Effectiveness:** Its ability to improve formulation efficiency can lead to reduced production costs and increased accessibility of medications.
These advantages highlight the growing significance of CAS 35180-01-9 in pharmaceutical research and development.

5. Applications of CAS 35180-01-9 in Various Therapeutics

CAS 35180-01-9 finds applications across a wide range of therapeutic areas. Some notable applications include:
- **Analgesics and Antipyretics:** Enhancing the solubility of pain relief medications ensures rapid onset and sustained effects.
- **Antibiotics:** Improving the stability and bioavailability of antibiotics can lead to more effective treatments for bacterial infections.
- **Anticancer Agents:** CAS 35180-01-9 can aid in the formulation of targeted therapies, improving drug delivery to cancerous tissues.
The versatility of CAS 35180-01-9 makes it an essential component in advancing therapeutic options across various medical fields.

6. Safety and Regulatory Aspects of CAS 35180-01-9

When incorporating CAS 35180-01-9 into pharmaceutical formulations, safety and regulatory compliance are paramount. Regulatory agencies, such as the FDA and EMA, require thorough testing to ensure that compounds used in drug formulation meet safety and efficacy standards.
The compound’s safety profile is essential for manufacturers to establish trust and credibility. Conducting preclinical and clinical trials, alongside adhering to Good Manufacturing Practices (GMP), ensures that CAS 35180-01-9 is safe for human use.

7. Case Studies: Successful Implementations of CAS 35180-01-9

Real-world applications of CAS 35180-01-9 illustrate its potential in drug formulation. For instance, a study involving the formulation of an analgesic demonstrated that the inclusion of CAS 35180-01-9 improved the solubility and onset of action significantly, leading to better patient outcomes.
Another case study focused on an antibiotic formulation that utilized CAS 35180-01-9 to enhance stability and bioavailability, resulting in a more effective treatment for patients with resistant bacterial infections.
These case studies underscore the transformative impact of CAS 35180-01-9 in the pharmaceutical industry.

8. Future Trends in Drug Formulation Using CAS 35180-01-9

The future of drug formulation utilizing CAS 35180-01-9 looks promising, with trends indicating increased research and innovation. The ongoing focus on personalized medicine and targeted therapies will likely drive the demand for compounds that enhance drug delivery and efficacy.
Additionally, advancements in nanotechnology and biotechnology may further optimize the utilization of CAS 35180-01-9, leading to the development of novel formulations with improved therapeutic outcomes.

9. Conclusion

In conclusion, CAS 35180-01-9 plays a critical role in the formulation of effective pharmaceutical products. By enhancing drug solubility, stability, and bioavailability, this compound significantly contributes to the advancement of therapeutic options across various medical fields. The ongoing exploration of its applications and benefits will undoubtedly lead to improved healthcare solutions, making CAS 35180-01-9 an indispensable asset in pharmaceutical development.

10. Frequently Asked Questions

What is CAS 35180-01-9?

CAS 35180-01-9 is a pharmaceutical intermediate used in drug formulation to enhance the solubility, stability, and overall efficacy of therapeutic agents.

What are the benefits of using CAS 35180-01-9 in drug formulation?

The benefits include improved drug efficacy, increased stability, versatility in applications, and cost-effectiveness in production.

In which therapeutic areas is CAS 35180-01-9 commonly used?

CAS 35180-01-9 is widely used in analgesics, antibiotics, and anticancer formulations, among others.

Are there any safety concerns related to CAS 35180-01-9?

Safety profiles are established through rigorous testing and regulatory compliance to ensure the compound is safe for human use.

What does the future hold for CAS 35180-01-9 in pharmaceuticals?

The future trends indicate increased research, innovation, and applications, particularly in personalized medicine and targeted therapies.
By presenting a comprehensive and detailed exploration of CAS 35180-01-9, this article aims to provide valuable insights and information to stakeholders in the pharmaceutical industry.